During the past decade, National Cardiovascular Center Harapan Kita conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cardiovascular Center Harapan Kita" #1 sponsor was "National Cardiovascular Center Harapan Kita Hospital Indonesia" with 9 trials, followed by "Indonesia University" with 5 trials sponsored, "Innogene Kalbiotech Pte. Ltd" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Chinese University of Hong Kong" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cardiovascular Center Harapan Kita" #1 collaborator was "National Cardiovascular Center Harapan Kita Hospital Indonesia" with 3 trials as a collaborator, "Angel Women and Children Hospital" with 1 trials as a collaborator, "Hanoi Obstetrics and Gynecology Hospital" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "National Cardiovascular Center Harapan Kita" are "Coronary Artery Disease" (5 trials), "Cardiopulmonary Bypass" (4 trials), "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials) and "Congenital Heart Disease" (2 trials). Many other conditions were trialed in "National Cardiovascular Center Harapan Kita" in a lesser frequency.

Most popular intervention types in "National Cardiovascular Center Harapan Kita" are "Drug" (11 trials), "Device" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexmedetomidine Hcl 100 Mcg/mL Inj" (2 trials), "Hypertonic lactate" (2 trials), "Intra Aortic Balloon Pump" (2 trials) and "Placebo oral capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Cardiovascular Center Harapan Kita" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Cardiovascular Center Harapan Kita". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in National Cardiovascular Center Harapan Kita, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cardiovascular Center Harapan Kita, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".